£456.00
Additional information
| Active substance | Onabotulinumtoxina |
|---|---|
| Water Retention | No significant effect |
| Hepatotoxicity | No known hepatotoxic effects |
| Lab Test | Mouse bioassay for potency testing |
| Also known as | Botox, onabotulinumtoxinA |
| Blood pressure | No significant effect |
| Trade name | Botox, Dysport, Xeomin |
| FORM | Injection |
| ean13 | 1398447472375 |
| Reference | SPRM039 |
| Storage conditions | Refrigerated, 2-8В°C |
| Chemical name | Botulinum toxin type A |
| Formula | C6760H10447N1743O2010S32 |
| Substance class | Neurotoxin |
| Main action | Blocks the release of acetylcholine at neuromuscular junctions |
| Half-life | 2-6 months |
| Dosage (medical) | 20-100 units injected intramuscularly, depending on treatment area |
| Dosage (sports) | Not applicable |
| Effects | Reduces muscle activity, treats wrinkles, muscle spasms, and excessive sweating |
| Side effects | Pain at injection site, headache, muscle weakness, drooping eyelids, dysphagia, spread of toxin effects |
| Use in sports | None, usage in sports would be considered misuse |
